Interestingly, Spiegelberg et al. [49] recently showed by PET imaging with 124I-labeled cetuximab that HSP90 inhibition induced a decreased in EGFR expression in head and neck squamous cell carcinoma. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.